Incentive Design Through Stock Option Grants to Officers and Employees
First written in FY2017-Q2. 9 of 12 entries say "Advanced", first in FY2017. Latest entry: 2026-10-16.
15 other companies' latest entry also says "Advanced".
- FY2021RestatedAnnual report
「Other (allocation as restricted stock compensation) 36,341 50,332,285 Other (exercise of stock options) 22,100 30,630,600」
No new stock options were issued, while 36,341 restricted shares were allocated and share acquisition rights representing 22,100 shares were exercised. - FY2021-Q2AdvancedAnnual report
「Note: Increases from purchases of less-than-one-unit shares and decreases from the allocation of 36 thousand restricted shares and the exercise of share acquisition rights representing 22 thousand shares.」
While no new stock options were issued, 36 thousand restricted shares were allocated and share acquisition rights representing 22 thousand shares were exercised, advancing the transition to stock-based compensation. - FY2020-Q2AdvancedAnnual report
「Note: Increases from purchases of less-than-one-unit shares and decreases from the allocation of 46 thousand restricted shares and the exercise of share acquisition rights representing 24 thousand shares.」
While no new stock options were issued, 46 thousand restricted shares were allocated, giving concrete form to the transition to stock-based compensation announced in the previous fiscal year. - FY2019ReframedAnnual report
「The stock-based compensation plan for directors, audit & supervisory board members and executive officers will also be discontinued, and no new grants will be made going forward.」
It indicated a policy of discontinuing the existing stock option plan and transitioning to restricted stock compensation for eligible directors. Director compensation will consist approximately of basic compensation, bonuses and stock-based compensation in a 6:1:3 ratio, with restricted stock compensation capped at ¥80 million per year and consolidated ROE and market capitalization set as target metrics for bonuses. - FY2019-Q2AdvancedAnnual report
「2018 Stock Options Categories and number of grantees 9 directors, 4 audit & supervisory board members and 5 executive officers Number of stock options granted by class of shares (Note) Common shares 48,300 Grant date 31 July 2018」
Under the 2018 stock option plan, 48,300 common shares were granted to 9 directors, 4 audit & supervisory board members and 5 executive officers. The exercise period is from 1 August 2018 to 30 July 2048, and the exercise price is ¥1 per share. - FY2018-Q2AdvancedAnnual report
「Current interim consolidated accounting period (from 1 April 2017 to 30 September 2017) 2017 Stock Options Categories and number of grantees 8 directors, 4 audit & supervisory board members and 5 executive officers Number of stock options granted by class of shares (Note) Common shares 52,100 Grant date 31 July 2017」
Following the Board of Directors resolution disclosed previously, it disclosed the grant of options representing 52,100 shares to directors, audit & supervisory board members and executive officers, with a grant date of 31 July 2017, under the 2017 stock option plan. - FY2017AdvancedAnnual report
「Approved by resolution of the Board of Directors on 28 June 2017」
At a Board of Directors meeting held on 28 June 2017, the company approved the issuance of 52,100 common shares under the Seventh Series of Share Acquisition Rights to 8 directors, 4 audit & supervisory board members and 5 executive officers. - FY2017-Q2First statedAnnual report
「2016 Stock Options Number of stock options granted by class of shares (Note): Common shares 66,200 Grant date: 29 July 2016 Exercise period: 1 August 2016 to 30 July 2046 Exercise price: ¥1」
Share acquisition rights representing 66,200 common shares were granted to 8 directors, 3 audit & supervisory board members and 5 executive officers. No vesting conditions or requisite service period were specified, and the fair value per unit on the grant date was ¥1,015.